522 Prevalence Of Atherosclerotic Plaque Types In Patients With Diabetes And Metabolic Syndrome

Abstract

Introduction: Previous studies have demonstrated that patients with diabetes (DM) and metabolic syndrome (MetS) have higher atherosclerotic plaque burden that increases their risk for major adverse cardiovascular events (MACE). Furthermore, recent studies have also shown that low attenuation plaque (LAP) is commonly associated with adverse CV events. In this study, we aim to evaluate the prevalence of low-attenuated plaque and other plaque types in patients with DM and MetS